Basic Information
ID: ALA4352898
Type: Binding
Description: Inhibition of capsid protein in Hepatitis B virus infected in human HepG2.2.15 cells assessed as reduction in viral DNA level supplemented with fresh medium containing compound every 2 days and measured after 6 days by RT-PCR analysis relative to control
Organism: Hepatitis B virus
Activity Charts
Bioactivity
Activity Types for Assay ALA4352898
Inhibition
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 229.26 | -0.59 | -0.59 |
| 378.52 | 5.11 | 5.11 |
| 398.94 | 5.45 | 5.45 |
| 408.55 | 5.12 | 5.12 |
| 520.42 | 5.41 | 5.41 |
| 451.62 | 4.74 | 4.74 |
| 364.50 | 4.80 | 4.80 |
| 523.68 | 4.95 | 4.95 |
| 562.45 | 5.61 | 5.61 |
| 380.49 | 4.50 | 4.50 |
| 471.00 | 5.66 | 5.66 |
| 382.49 | 4.94 | 4.94 |
| 428.97 | 5.46 | 5.46 |
| 412.51 | 4.95 | 4.95 |
| 509.70 | 5.53 | 5.53 |
| 436.56 | 5.01 | 5.01 |
| 473.42 | 5.57 | 5.57 |
| 515.45 | 5.77 | 5.77 |
| 452.56 | 4.72 | 4.72 |
| 481.64 | 4.75 | 4.75 |
| 479.67 | 5.52 | 5.52 |
| 394.52 | 4.81 | 4.81 |
| 450.59 | 5.32 | 5.32 |
| 443.39 | 5.56 | 5.56 |
| 454.55 | 5.15 | 5.15 |
| 490.39 | 5.40 | 5.40 |
| 551.73 | 5.73 | 5.73 |
| 410.52 | 4.51 | 4.51 |